FDA-approved drug targets a mutated gene identified in 2008 by Hopkins cancer expert Bert Vogelstein and his team in collaboration with Duke researchers
Douville and his team use machine learning techniques to detect early cancer warning signs; $250,000 award will support the translation of this work to tools and technologies that benefit patients
The President's Venture Fellowship provides significant funding to a graduating student who intends to continue a promising business venture in Baltimore